Founded in 2000, Benchmark has been built through organic innovation and strategic acquisitions. In 2013, we listed on the AIM market of the London Stock Exchange.
June 2018
Launched Benchmark Genetics in Chile
May 2018
Becomes one of only 5 companies to feature in the London Stock Exchange Group’s ‘1000 Companies to Inspire Britain’ report for 5th Consecutive year.
March 2018
Reached 1,000 employees
March 2017
Signed a long-term agreement with SalMar, one of the world’s leading salmon producers, to provide genetics, health and knowledge services to the company.
Aug 2016
Added shrimp to our aquaculture breeding business through the acquisition of a South American shrimp breeding programme.
Dec 2015
Acquired the number 1 advanced aquaculture nutrition provider, INVE Aquaculture.
July 2015
Added Norwegian, Akvaforsk Genetics Center AS, and tilapia breeding company, Spring Genetics to strengthen our genetics offering.
Dec 2014
Completed an acquisition of the second and third-ranked international salmon breeding companies, SalmoBreed and StofnFiskur.
Dec 2013
Floated on the London Stock Exchange AIM market.
Sept 2012
Acquired Novartis’s vaccine manufacturing plant in Braintree, UK.
July 2000
Benchmark is established to drive improvements in the food supply chain.
